Use of off-label doses is frequent in biologic therapy for moderate to severe psoriasis: A cross-sectional study in clinical practice
11/06/2018
Carrascosa JM, Garcia-Doval I, Perez-Zafrilla B, Carretero G, Vanaclocha F, Dauden E, et al.
Descargar documento
J Dermatol Treat 2015;26(6):502-6. PMID: 25886087